BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21983936)

  • 1. A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma.
    Kadota K; Suzuki K; Colovos C; Sima CS; Rusch VW; Travis WD; Adusumilli PS
    Mod Pathol; 2012 Feb; 25(2):260-71. PubMed ID: 21983936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.
    Rosen LE; Karrison T; Ananthanarayanan V; Gallan AJ; Adusumilli PS; Alchami FS; Attanoos R; Brcic L; Butnor KJ; Galateau-Sallé F; Hiroshima K; Kadota K; Klampatsa A; Stang NL; Lindenmann J; Litzky LA; Marchevsky A; Medeiros F; Montero MA; Moore DA; Nabeshima K; Pavlisko EN; Roggli VL; Sauter JL; Sharma A; Sheaff M; Travis WD; Vigneswaran WT; Vrugt B; Walts AE; Tjota MY; Krausz T; Husain AN
    Mod Pathol; 2018 Apr; 31(4):598-606. PubMed ID: 29327706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic features predict survival in diffuse pleural malignant mesothelioma on pleural biopsies.
    Habougit C; Trombert-Paviot B; Karpathiou G; Casteillo F; Bayle-Bleuez S; Fournel P; Vergnon JM; Tiffet O; Péoc'h M; Forest F
    Virchows Arch; 2017 Jun; 470(6):639-646. PubMed ID: 28349237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined grade and nuclear grade are prognosis predictors of epithelioid malignant peritoneal mesothelioma: a multi-institutional retrospective study.
    Benzerdjeb N; Dartigues P; Kepenekian V; Valmary-Degano S; Mery E; Averous G; Chevallier A; Laverriere MH; Villa I; Sallé FG; Villeneuve L; Glehen O; Isaac S; Hommell-Fontaine J;
    Virchows Arch; 2021 Nov; 479(5):927-936. PubMed ID: 34169365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on survival of nuclear atypia in epithelioid malignant mesothelioma.
    Mlika M; Limam M; Benzarti A; Mezni F
    Adv Respir Med; 2019; 87(2):90-95. PubMed ID: 31038719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications.
    Forest F; Patoir A; Dal Col P; Sulaiman A; Camy F; Laville D; Bayle-Bleuez S; Fournel P; Habougit C
    Pathology; 2018 Oct; 50(6):635-641. PubMed ID: 30145072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of pleomorphic features but not growth patterns improves prognostic stratification of epithelioid malignant pleural mesothelioma by 2-tier nuclear grade.
    Zhang YZ; Brambilla C; Molyneaux PL; Rice A; Robertus JL; Jordan S; Lim E; Lang-Lazdunski L; Begum S; Dusmet M; Anikin V; Beddow E; Finch J; Asadi N; Popat S; Quesne JL; Husain AN; Cookson WOCM; Moffatt MF; Nicholson AG
    Histopathology; 2020 Sep; 77(3):423-436. PubMed ID: 32333813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Histomorphologic Grading System That Predicts Overall Survival in Diffuse Malignant Peritoneal Mesothelioma With Epithelioid Subtype.
    Valente K; Blackham AU; Levine E; Russell G; Votanopoulos KI; Stewart JH; Shen P; Geisinger KR; Sirintrapun SJ
    Am J Surg Pathol; 2016 Sep; 40(9):1243-8. PubMed ID: 27438989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma.
    Kadota K; Suzuki K; Sima CS; Rusch VW; Adusumilli PS; Travis WD
    J Thorac Oncol; 2011 May; 6(5):896-904. PubMed ID: 21358344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Nuclear Grading System in Epithelioid Malignant Pleural Mesothelioma in Biopsy-heavy Setting: An External Validation Study of 563 Cases.
    Zhang YZ; Brambilla C; Molyneaux PL; Rice A; Robertus JL; Jordan S; Lim E; Lang-Lazdunski L; Begum S; Dusmet M; Anikin V; Beddow E; Finch J; Asadi N; Popat S; Cookson WOC; Moffatt MF; Nicholson AG
    Am J Surg Pathol; 2020 Mar; 44(3):347-356. PubMed ID: 32045387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological features of epithelioid malignant pleural mesotheliomas in patients with extended survival.
    Paajanen J; Laaksonen S; Kettunen E; Ilonen I; Vehmas T; Salo J; Räsänen J; Sutinen E; Ollila H; Mäyränpää MI; Myllärniemi M; Wolff H
    Hum Pathol; 2020 Apr; 98():110-119. PubMed ID: 32142836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.
    Ghanim B; Klikovits T; Hoda MA; Lang G; Szirtes I; Setinek U; Rozsas A; Renyi-Vamos F; Laszlo V; Grusch M; Filipits M; Scheed A; Jakopovic M; Samarzija M; Brcic L; Stancic-Rokotov D; Kern I; Rozman A; Dekan G; Klepetko W; Berger W; Glasz T; Dome B; Hegedus B
    Br J Cancer; 2015 Mar; 112(5):783-92. PubMed ID: 25633038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.
    Kadota K; Suzuki K; Kachala SS; Zabor EC; Sima CS; Moreira AL; Yoshizawa A; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
    Mod Pathol; 2012 Aug; 25(8):1117-27. PubMed ID: 22499226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma.
    Vivero M; Bueno R; Chirieac LR
    Mod Pathol; 2018 Jan; 31(1):122-131. PubMed ID: 28884745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma.
    Kadota K; Villena-Vargas J; Nitadori J; Sima CS; Jones DR; Travis WD; Adusumilli PS
    Ann Surg Oncol; 2015 Sep; 22(9):3136-43. PubMed ID: 25608772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amount of Epithelioid Differentiation Is a Predictor of Survival in Malignant Pleural Mesothelioma.
    Vigneswaran WT; Kircheva DY; Ananthanarayanan V; Watson S; Arif Q; Celauro AD; Kindler HL; Husain AN
    Ann Thorac Surg; 2017 Mar; 103(3):962-966. PubMed ID: 27765170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.
    Frischknecht L; Meerang M; Soltermann A; Stahel R; Moch H; Seifert B; Weder W; Opitz I
    J Thorac Cardiovasc Surg; 2015 Jun; 149(6):1539-46.e1. PubMed ID: 25840756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients.
    Suzuki K; Kadota K; Sima CS; Sadelain M; Rusch VW; Travis WD; Adusumilli PS
    Cancer Immunol Immunother; 2011 Dec; 60(12):1721-8. PubMed ID: 21769693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype.
    Beer TW; Buchanan R; Matthews AW; Stradling R; Pullinger N; Pethybridge RJ
    Hum Pathol; 1998 Mar; 29(3):246-51. PubMed ID: 9496827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy.
    Brimo F; Robinson B; Guo C; Zhou M; Latour M; Epstein JI
    Am J Surg Pathol; 2010 May; 34(5):715-22. PubMed ID: 20410812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.